TRCT
XRAY icon

Tower Research Capital (TRC)’s Dentsply Sirona XRAY Stock Holding History

Tower Research Capital (TRC)’s Portfolio XRAY Stock Details XRAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$177K Sell
15,277
-22,653
-60% -$283K ﹤0.01% 1713
2025
Q4 		$434K Buy
37,930
+28,222
+291% +$331K 0.01% 908
2025
Q3 		$123K Sell
9,708
-5,565
-36% -$80.7K ﹤0.01% 1838
2025
Q2 		$243K Buy
15,273
+3,219
+27% +$48.1K 0.01% 1600
2025
Q1 		$180K Sell
12,054
-14,318
-54% -$254K 0.01% 1426
2024
Q4 		$501K Buy
26,372
+22,617
+602% +$478K 0.01% 1059
2024
Q3 		$102K Sell
3,755
-45,871
-92% -$1.17M ﹤0.01% 2225
2024
Q2 		$1.24M Buy
49,626
+41,836
+537% +$1.2M 0.02% 636
2024
Q1 		$259K Sell
7,790
-22,684
-74% -$775K 0.01% 1247
2023
Q4 		$1.08M Buy
30,474
+17,764
+140% +$564K 0.01% 799
2023
Q3 		$434K Buy
12,710
+7,162
+129% +$272K 0.01% 952
2023
Q2 		$222K Sell
5,548
-13,299
-71% -$529K 0.01% 1486
2023
Q1 		$741K Buy
18,847
+7,823
+71% +$287K 0.02% 605
2022
Q4 		$351K Sell
11,024
-28,242
-72% -$851K 0.01% 918
2022
Q3 		$1.11M Buy
39,266
+25,177
+179% +$861K 0.02% 662
2022
Q2 		$503K Sell
14,089
-22,797
-62% -$922K 0.01% 1131
2022
Q1 		$1.82M Buy
36,886
+21,148
+134% +$1.12M 0.02% 595
2021
Q4 		$878K Buy
15,738
+11,647
+285% +$641K 0.02% 761
2021
Q3 		$238K Sell
4,091
-1,425
-26% -$87.8K 0.01% 1651
2021
Q2 		$349K Sell
5,516
-30,667
-85% -$2.02M 0.01% 1473
2021
Q1 		$2.31M Buy
36,183
+28,672
+382% +$1.66M 0.04% 428
2020
Q4 		$393K Buy
7,511
+2,874
+62% +$142K 0.01% 1185
2020
Q3 		$203K Sell
4,637
-17,376
-79% -$768K ﹤0.01% 2564
2020
Q2 		$970K Buy
22,013
+4,194
+24% +$177K 0.04% 545
2020
Q1 		$692K Buy
17,819
+16,240
+1,028% +$827K 0.04% 321
2019
Q4 		$89K Sell
1,579
-2,028
-56% -$113K 0.01% 1004
2019
Q3 		$192K Buy
+3,607
New +$194K 0.01% 1028
2019
Q2 		– Sell
-10,026
Closed -$497K – 4387
2019
Q1 		$497K Sell
10,026
-7,007
-41% -$309K 0.03% 605
2018
Q4 		$634K Buy
17,033
+14,178
+497% +$516K 0.05% 368
2018
Q3 		$107K Sell
2,855
-8,197
-74% -$341K 0.01% 1304
2018
Q2 		$484K Buy
+11,052
New +$519K 0.03% 658
2018
Q1 		– Sell
-6,626
Closed -$436K – 3920
2017
Q4 		$436K Buy
6,626
+6,066
+1,083% +$386K 0.06% 328
2017
Q3 		$33K Buy
+560
New +$33.3K ﹤0.01% 2364
2017
Q1 		– Sell
-3,188
Closed -$184K – 4021
2016
Q4 		$184K Buy
+3,188
New +$188K 0.02% 664
2016
Q3 		– Sell
-6,180
Closed -$384K – 4554
2016
Q2 		$384K Buy
+6,180
New +$380K 0.04% 346
2016
Q1 		– Sell
-124
Closed -$8K – 5048
2015
Q4 		$8K Sell
124
-2,452
-95% -$146K ﹤0.01% 2465
2015
Q3 		$130K Buy
+2,576
New +$137K 0.01% 443
2015
Q1 		– Sell
-171
Closed -$9K – 5007
2014
Q4 		$9K Sell
171
-74
-30% -$3.77K ﹤0.01% 2262
2014
Q3 		$11K Buy
245
+90
+58% +$4.23K ﹤0.01% 2771
2014
Q2 		$8K Sell
155
-1,007
-87% -$46.8K ﹤0.01% 2547
2014
Q1 		$54K Sell
1,162
-1,081
-48% -$50K 0.01% 1041
2013
Q4 		$109K Sell
2,243
-1,723
-43% -$80.6K 0.02% 814
2013
Q3 		$173K Buy
3,966
+2,292
+137% +$97.8K 0.02% 850
2013
Q2 		$69K Buy
+1,674
New +$69.8K 0.01% 712

Other funds holding XRAY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
SCA
Southpoint Capital Advisors New York $4.86B AUM 34.09% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

Tower Research Capital (TRC)'s XRAY Position: Q1 2026 in Review

Tower Research Capital (TRC) reduced its Dentsply Sirona (XRAY) stake by 60% in Q1 2026, selling an estimated $283K and leaving 15,277 shares worth $177K. The position accounts for ﹤0.01% of the portfolio, ranked #1713.

Tower Research Capital (TRC) first reported a position in XRAY in Q2 2013 and has held it in 44 quarters since. The position peaked at $2.31M in Q1 2021. 382 funds tracked by Wall St. Rank hold XRAY as of Q1 2026.

  • Tower Research Capital (TRC) held 15,277 shares of Dentsply Sirona worth $177K as of Q1 2026.
  • Tower Research Capital (TRC) sold 22,653 Dentsply Sirona shares in Q1 2026, an estimated $283K.
  • Dentsply Sirona made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #1713 holding.
  • Tower Research Capital (TRC) first reported a position in Dentsply Sirona in Q2 2013 and has held it in 44 quarters since.
  • Tower Research Capital (TRC)'s Dentsply Sirona position peaked at $2.31M in Q1 2021.
  • 382 funds tracked by Wall St. Rank held Dentsply Sirona as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.